vs
Side-by-side financial comparison of SELECT MEDICAL HOLDINGS CORP (SEM) and StoneX Group Inc. (SNEX). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.2B, roughly 1.2× StoneX Group Inc.). StoneX Group Inc. runs the higher net margin — 11.6% vs 1.4%, a 10.1% gap on every dollar of revenue. On growth, StoneX Group Inc. posted the faster year-over-year revenue change (81.0% vs 6.4%). SELECT MEDICAL HOLDINGS CORP produced more free cash flow last quarter ($5.2M vs $-1.3B). Over the past eight quarters, StoneX Group Inc.'s revenue compounded faster (53.5% CAGR vs 2.8%).
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
StoneX Group Inc. is an American financial services company. The company operates in six areas: commercial hedging, global payments, securities, physical commodities, foreign exchange and clearing and execution services (CES).
SEM vs SNEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.2B |
| Net Profit | $20.2M | $139.0M |
| Gross Margin | — | — |
| Operating Margin | 4.6% | 15.4% |
| Net Margin | 1.4% | 11.6% |
| Revenue YoY | 6.4% | 81.0% |
| Net Profit YoY | 225.7% | 63.3% |
| EPS (diluted) | $0.17 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.4B | $32.7B | ||
| Q2 25 | $1.3B | $851.2M | ||
| Q1 25 | $1.4B | $820.4M | ||
| Q4 24 | $1.3B | $663.1M | ||
| Q3 24 | $1.3B | $31.1B | ||
| Q2 24 | $1.3B | $571.8M | ||
| Q1 24 | $1.3B | $509.2M |
| Q4 25 | $20.2M | $139.0M | ||
| Q3 25 | $28.8M | $85.7M | ||
| Q2 25 | $40.6M | $63.4M | ||
| Q1 25 | $56.7M | $71.7M | ||
| Q4 24 | $-16.1M | $85.1M | ||
| Q3 24 | $55.6M | $76.7M | ||
| Q2 24 | $77.6M | $61.9M | ||
| Q1 24 | $96.9M | $53.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 4.6% | 15.4% | ||
| Q3 25 | 5.4% | 0.3% | ||
| Q2 25 | 6.5% | -1.3% | ||
| Q1 25 | 8.3% | -1.0% | ||
| Q4 24 | 1.6% | -3.2% | ||
| Q3 24 | 4.3% | -0.0% | ||
| Q2 24 | 5.8% | -4.7% | ||
| Q1 24 | 9.0% | -2.5% |
| Q4 25 | 1.4% | 11.6% | ||
| Q3 25 | 2.1% | 0.3% | ||
| Q2 25 | 3.0% | 7.4% | ||
| Q1 25 | 4.2% | 8.7% | ||
| Q4 24 | -1.2% | 12.8% | ||
| Q3 24 | 4.4% | 0.2% | ||
| Q2 24 | 6.1% | 10.8% | ||
| Q1 24 | 7.3% | 10.4% |
| Q4 25 | $0.17 | $2.50 | ||
| Q3 25 | $0.23 | $0.72 | ||
| Q2 25 | $0.32 | $1.22 | ||
| Q1 25 | $0.44 | $1.41 | ||
| Q4 24 | $-0.12 | $1.69 | ||
| Q3 24 | $0.43 | $2.32 | ||
| Q2 24 | $0.60 | $1.25 | ||
| Q1 24 | $0.75 | $1.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.5M | $1.6B |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $1.7B | $2.5B |
| Total Assets | $5.9B | $47.8B |
| Debt / EquityLower = less leverage | 1.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.5M | $1.6B | ||
| Q3 25 | $60.1M | $1.6B | ||
| Q2 25 | $52.3M | $1.3B | ||
| Q1 25 | $53.2M | $1.3B | ||
| Q4 24 | $59.7M | $1.4B | ||
| Q3 24 | $191.5M | $1.3B | ||
| Q2 24 | $111.2M | $1.2B | ||
| Q1 24 | $92.6M | $1.3B |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.6B | — | ||
| Q1 24 | $3.8B | — |
| Q4 25 | $1.7B | $2.5B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.7B | $2.0B | ||
| Q1 25 | $1.7B | $1.9B | ||
| Q4 24 | $1.7B | $1.8B | ||
| Q3 24 | $1.9B | $1.7B | ||
| Q2 24 | $1.4B | $1.6B | ||
| Q1 24 | $1.4B | $1.5B |
| Q4 25 | $5.9B | $47.8B | ||
| Q3 25 | $5.7B | $45.3B | ||
| Q2 25 | $5.7B | $34.3B | ||
| Q1 25 | $5.7B | $31.3B | ||
| Q4 24 | $5.6B | $29.6B | ||
| Q3 24 | $8.0B | $27.5B | ||
| Q2 24 | $7.9B | $25.9B | ||
| Q1 24 | $7.9B | $25.7B |
| Q4 25 | 1.06× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.10× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | 1.01× | — | ||
| Q3 24 | 1.62× | — | ||
| Q2 24 | 2.54× | — | ||
| Q1 24 | 2.75× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.3M | $-1.3B |
| Free Cash FlowOCF − Capex | $5.2M | $-1.3B |
| FCF MarginFCF / Revenue | 0.4% | -106.4% |
| Capex IntensityCapex / Revenue | 4.2% | 1.3% |
| Cash ConversionOCF / Net Profit | 3.19× | -9.08× |
| TTM Free Cash FlowTrailing 4 quarters | $117.2M | $3.5B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.3M | $-1.3B | ||
| Q3 25 | $175.3M | $3.5B | ||
| Q2 25 | $110.3M | $1.5B | ||
| Q1 25 | $-3.5M | $-154.5M | ||
| Q4 24 | $125.4M | $-477.8M | ||
| Q3 24 | $181.0M | $192.6M | ||
| Q2 24 | $278.2M | $-622.1M | ||
| Q1 24 | $-66.7M | $784.0M |
| Q4 25 | $5.2M | $-1.3B | ||
| Q3 25 | $122.2M | $3.5B | ||
| Q2 25 | $45.6M | $1.5B | ||
| Q1 25 | $-55.8M | $-169.8M | ||
| Q4 24 | $62.0M | $-491.4M | ||
| Q3 24 | $130.3M | $175.9M | ||
| Q2 24 | $222.6M | $-640.5M | ||
| Q1 24 | $-119.2M | $766.6M |
| Q4 25 | 0.4% | -106.4% | ||
| Q3 25 | 9.0% | 10.7% | ||
| Q2 25 | 3.4% | 173.3% | ||
| Q1 25 | -4.1% | -20.7% | ||
| Q4 24 | 4.7% | -74.1% | ||
| Q3 24 | 10.2% | 0.6% | ||
| Q2 24 | 17.4% | -112.0% | ||
| Q1 24 | -9.0% | 150.5% |
| Q4 25 | 4.2% | 1.3% | ||
| Q3 25 | 3.9% | 0.1% | ||
| Q2 25 | 4.8% | 1.9% | ||
| Q1 25 | 3.9% | 1.9% | ||
| Q4 24 | 4.8% | 2.1% | ||
| Q3 24 | 4.0% | 0.1% | ||
| Q2 24 | 4.3% | 3.2% | ||
| Q1 24 | 4.0% | 3.4% |
| Q4 25 | 3.19× | -9.08× | ||
| Q3 25 | 6.09× | 41.18× | ||
| Q2 25 | 2.72× | 23.52× | ||
| Q1 25 | -0.06× | -2.15× | ||
| Q4 24 | — | -5.61× | ||
| Q3 24 | 3.25× | 2.51× | ||
| Q2 24 | 3.59× | -10.05× | ||
| Q1 24 | -0.69× | 14.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
SNEX
Segment breakdown not available.
